Published in J Clin Pathol on June 01, 1979
Enzyme-linked immunosorbent assay for measurement of antibody against cytomegalovirus and rubella virus in a single serum dilution. J Clin Pathol (1981) 1.91
Rubella antibodies detected by several commercial immunoassays in hemagglutination inhibition-negative sera. J Clin Microbiol (1983) 1.85
Detection of rubella antibodies by hemagglutination inhibition, indirect fluorescent-antibody test, and enzyme-linked immunosorbent assay. J Clin Microbiol (1981) 1.65
Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus. J Clin Microbiol (1982) 1.38
Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana. Am J Public Health (2000) 1.14
Use of enzyme immunoassays and the latex agglutination test to measure the temporal appearance of immunoglobulin G and M antibodies after natural infection or immunization with rubella virus. J Clin Microbiol (1983) 1.05
Is post partum rubella vaccination worthwhile? J Clin Pathol (1982) 0.96
Evaluation of a latex agglutination test for detection of antibodies to rubella virus in selected sera. J Clin Microbiol (1983) 0.95
Hotting-up the complement-fixation test. J Hyg (Lond) (1983) 0.90
Rubella antibody determination from heparinised finger-tip blood by single radial haemolysis and enzyme immunoassay. J Clin Pathol (1980) 0.83
Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females. Bull World Health Organ (1985) 0.75
Enzyme-linked immunosorbent assay for the diagnosis of recent rubella infection. J Clin Pathol (1982) 0.75
Antibody against viruses in maternal and cord sera: non-specific inhibitors are found to higher titre on the maternal side of the circulation. J Hyg (Lond) (1984) 0.75
Rubella-virus hemagglutination-inhibition test. N Engl J Med (1967) 14.99
A simple method for detecting antibodies to rubella. Br J Exp Pathol (1975) 5.80
A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood. Am J Epidemiol (1968) 2.36
The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service collaborative survey. J Hyg (Lond) (1978) 1.96
Evaluation of the hemolysis-in-gel test for the screening of rubella immunity and the demonstration of recent infection. J Clin Microbiol (1976) 1.88
A comparative study of methods used for removing non-specific inhibitors of rubella haemagglutination from human sera. Med Lab Technol (1975) 1.16
Evaluation of the single radial haemolysis (SRH) technique for rubella antibody measurement. J Clin Pathol (1978) 1.02
An assessment of radial haemolysis in the detection of rubella antibody. J Clin Pathol (1978) 0.99
Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ (1976) 12.01
A simple method for detecting antibodies to rubella. Br J Exp Pathol (1975) 5.80
Microplate enzyme-linked immunosorbent assay for chagas' disease. Lancet (1975) 5.70
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet (1981) 4.62
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Immunofluorescence method suitable for large-scale application to malaria. Bull World Health Organ (1971) 4.46
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol (1993) 4.42
Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13
Enzyme immunoassays with special reference to ELISA techniques. J Clin Pathol (1978) 3.93
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
A microplate enzyme-immunoassay for toxoplasma antibody. J Clin Pathol (1976) 3.64
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J (1974) 3.42
Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination. Br J Exp Pathol (1976) 3.39
Simple, rapid method for assay of aminoglycoside antibiotics. Lancet (1971) 3.35
Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol (1979) 3.20
A microplate method of enzyme-linked immunosorbent assay and its application to malaria. Bull World Health Organ (1974) 2.66
Human parvovirus B19. BMJ (1994) 2.53
The detection of specific IgM antibodies following infection with rubella virus. J Clin Pathol (1975) 2.49
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
The communication of ELISA data from laboratory to clinician. J Immunoassay (1980) 2.39
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32
The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect (2000) 2.25
British psychiatry and homosexuality. Br J Psychiatry (1999) 2.15
Outcome of asymptomatic infection with rubella virus during pregnancy. J Hyg (Lond) (1981) 2.15
Immunosuppression during trypanosomiasis. Br J Exp Pathol (1972) 2.13
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) (1982) 2.09
A rationalised virological electron microscope specimen testing policy. PHLS North West Viral Gastroenteritis and Electron Microscopy Subcommittee. J Clin Pathol (1999) 2.09
Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08
The human parvovirus. Brief review. Arch Virol (1984) 2.05
The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service collaborative survey. J Hyg (Lond) (1978) 1.96
Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94
Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol (1996) 1.90
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med (1983) 1.89
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89
Enzyme immunoassays for parasitic diseases. Trans R Soc Trop Med Hyg (1976) 1.87
Therapeutic implications of interaction of gentamicin and penicillins. Lancet (1971) 1.85
The detection of viruses by enzyme-linked immunosorbent assay (ELISA). J Gen Virol (1976) 1.82
Malaria, anaemia and pregnancy. Ann Trop Med Parasitol (1969) 1.81
Splenomegaly in New Guinea. Bull World Health Organ (1967) 1.81
New serological test for malaria antibodies. Br Med J (1975) 1.74
Persistence of specific IgM after natural infection with rubella virus. Lancet (1975) 1.74
The spectrum of ocular toxocariasis. Eye (Lond) (1993) 1.73
A simple, inexpensive gel filtration technique for use in diagnostic serology. J Clin Pathol (1973) 1.72
Human parvovirus infection in homozygous sickle cell disease. Lancet (1993) 1.71
Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol (1993) 1.66
Factor-VIII-related antigen: measurement by enzyme immunoassay. Br Med J (1976) 1.64
Rapid assay of gentamicin. Lancet (1972) 1.64
Studies on immunoglobulins of Nigerians. I. The immunoglobulin levels of a Nigerian population. J Trop Med Hyg (1966) 1.59
Comparison of immunofluorescence and radioimmunoassay for detecting IgM antibody in infants with the congenital rubella syndrome. J Hyg (Lond) (1979) 1.57
The epidemiologic interpretation of serologic data in malaria. Am J Trop Med Hyg (1972) 1.56
Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol (2000) 1.55
Serological malaria surveys in Nigeria. Bull World Health Organ (1968) 1.55
The detection of rubella-specific IgM antibodies by radioimmunoassay. Br J Exp Pathol (1978) 1.54
Adenovirus types 40 and 41 and rotaviruses associated with diarrhea in children from Guatemala. J Clin Microbiol (1990) 1.54
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect (1995) 1.50
Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49
Enzyme immunoassays for viral diseases. J Infect Dis (1977) 1.46
Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) (1983) 1.45
Rash in early pregnancy. Br Med J (Clin Res Ed) (1983) 1.43
Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect (1988) 1.43
Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect (1994) 1.43
Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol (1982) 1.43
Variation in delayed hypersensitivity in onchocerciasis. Trans R Soc Trop Med Hyg (1978) 1.42
Diagnosis of invasive candidosis by enzyme immunoassay of serum antigen. Br Med J (1977) 1.41
Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev (1997) 1.40
Toxocariasis in the British Isles 1982-3. Br Med J (Clin Res Ed) (1984) 1.39
Psychotherapists' approaches to gay and lesbian patients/clients: a qualitative study. Br J Med Psychol (2001) 1.38
Quality of life in hospice patients. A pilot study. Psychosomatics (1999) 1.38
Serological reactions to infection with Necator americanus. Trans R Soc Trop Med Hyg (1969) 1.37
Suppression of autoimmune disease in NZB and (NZB x NZW) F1 hybrid mice by infection with malaria. Nature (1970) 1.37
Rubella-specific IgM detection using Sephacryl S-300 gel filtration. J Clin Pathol (1980) 1.36
End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36
Adenovirus type 7; 1971-74. Lancet (1976) 1.35
Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect (2006) 1.34
Can parasitic infection suppress autoimmune disease? Proc R Soc Med (1970) 1.33
Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev (1994) 1.32
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
The distribution of enzyme variation in populations of Plasmodium falciparum in Africa. Trans R Soc Trop Med Hyg (1975) 1.31
Immunological studies on simian malaria. 3. Immunity to challenge and antigenic variation in P. knowlesi. Trans R Soc Trop Med Hyg (1969) 1.31